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    Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important agents producing 
nosocomial diseases in hospitalized children. Then, screening of health care providers who are in direct 
contact with patients in hospital is necessary. The objective of this study was to investigate MRSA collected 
isolates for MLSB phenotypes, in particular inducible clindamycin resistance (MLSBi).Two hundred and 
twenty nine health care providers were examined and nasal samples for S. aureus culture and 
sociodemographic data were obtained from them during one year august 2012 - july 2013. After MRSA 
identification, all isolates were examined for antibiotic resistant pattern.Staphylococci were isolated from 27 
samples. Twenty one of them were MRSA. All isolates sensitive to linezolid and vancomycin. D-tests 
identified 6 isolates (28.6%) with inducible resistance to clindamycin (MLSBi phenotype). Carrier samples 
screening are considered less than clinical samples. Treatment of variety of infectious diseases due to 
resistant bacteria is difficult. So, annual screening of these individuals, detecting the carriers and 
decolonizing them to reduce transmission of S. aureus in the hospital is necessary.  
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INTRODUCTION 
     Staphylococcus aureus find nearly 25-30% on 
skin or nose of healthy people. MRSA is a type of 
Staphylococcus that is resistant to certain 
antibiotics such as methicillin, cloxacillin, 
dicloxacillin, oxacillin, nafcillin, and closely 
related class of drugs such as cephalosporins (e.g., 
cephalexin). One of the most important reasons of 
MRSA expansion is unnecessary and broad-
spectrum antibiotic overuse for less serious 
infections. Unfortunately, these MRSA isolates 
which susceptible only to glycopeptides antibiotics 
such as vancomycin, are becoming multidrug 
resistant [1].  
At present, low level resistance to vancomycin is 
appearing and increasing [2]. The possible 
predisposing factors of MRSA emergence are, long 
time hospitalization, consumption of antibiotics 
without  doctor prescription, lack of awareness, 
receipt of antibiotics before coming to the hospital 
and  etc [3] . MRSA serious infections have been 
increased in the world. Infected patients and health 
care providers carriers play important role in 
spreading and transferring this superbug in hospital 
[4]. Today, emergence of multiple drug resistance 
and monitoring of disease transmission by MRSA 
isolates not only in hospitals but also in 
communities is the major challenge [5]. A 
considerable increase in the prevalence of MRSA 
has been reported from every region of world. 
Treatment of the infections due to MRSA is 
difficult because of the restricted spectrum of 
antimicrobials of proven efficacy. A macrolide-
lincosamide-streptogramin B (MLSB) antibiotic, 
clindamycin, is a good substitute to treat these 
infections.But, there are reports of resistance to this 
drug too. A variety of erm genes, which may be 
expressed either constitutively (MLSBc 
phenotype) or inducibely (MLSBi phenotype) may 
be cause resistance to macrolide (MLSB).  
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Active efflux pump encoded by msr A gene (MS 
phenotype) is other mechanism of resistance. 
Beacause in treatment with clindamycin in vivo 
may result failure, thus detect this resistance by D 
test (double disc diffusion test) is necessary. 
Conventionally,laboratory susceptibility test for 
clindamycin usually cannot detect inducible 
clindamycin resistance and erythromycin resistant - 
clindamycin sensitive[6]. Variation of the 
prevalence of inducible clindamycin resistance in 
different geographical regions and different 
hospitals, we decide to study MRSA in health care 
providers for MLSBphenotypes, in particular 
inducible clindamycin resistance (MLSBi). 
 
MATERIAL AND METHODS 
      In this descriptive study, two hundred and 
twenty nine health care providers) such as nurses 
and health care workers) were examined from 
different wards in Mofid children hospital, Tehran, 
Iran. Office personnel were excluded. Nasal 
samples for examination of S. aureus isolated from 
persons during one year august 2012 - july 2013. 
All subjects in this study were without underlying 
diseases and were not taking antibiotics two weeks 
before sampling a sterile moistened swab was 
inserted into each nostril to approximately 1 cm 
depth, and rotated five times. The samples were 
transferred quickly to the laboratory and were 
inoculated onto mannitol salt agar medium and 
incubated at 35 °C for overnight. The isolates were 
identified as S. aureus based on morphologic and 
biochemical tests [7]. All the strains were screened 
for methicillin resistance by oxacillin (1µg) and 
cefoxitin (30 µg) disk diffusion test based on 
standard guidelines [8].  
Antibiotic resistant pattern  
    The resistant patterns of MSSA and MRSA 
strains were determined by disk diffusion method 
(Kirby–Bauer). The antibiotics panel was: 
penicillin (10units), cefpodoxime (10µg), oxacillin 
(1µg), vancomycin (30µg), linezolid (30µg), 
clindamycin (2µg), ciprofloxacin, rifampicin (5 
µg), teicoplanine (30 µg), cefepime, erythromycin 
(15µg), cefotaxim (30µg), azithromycine (15µg), 
and ceftazidim (30 µg), minocycline (30µg), 
doxycycline (30µg), trimethoprime-sulfametoxazol 
(25µg), ceftriaxone (30µg). Zone diameters were 
measured after 24 h incubation at 35₀C. Zone 
inhibition diameters as recommended by clinical 
and laboratory standards institute (CLSI 2012) 
American type culture collection (ATCC) 29213 S. 
aureus was used as the control strain [8]. All the 
isolates which showed clindamycin-erythromycin 
discordant sensitivity results were further subjected 
to D test as per CLSI guidelines. Briefly, 
erythromycin (15 µgm) disc was placed at a 
distance of 15mm (edge to edge) from clindamycin 
(2 µgm) disc on Muller- Hinton agar, previously 
inoculated 0.5 Mcfarland bacterial suspensions. 
Following overnight incubation at 37
o
C, flattening 
of zone (D shaped) around clindamycin in the area 
between the two discs indicated inducible 
clindamycin resistance [6]. 
Statistical analysis 
    Statistical analysis was conducted using the 
SPSS version 16. Fisher’s exact test was used to 
evaluation relation between MRSA and MSSA. P-




     In this study, 229 health care providers  (23-49 
years old) from different hospital wards(infectious, 
gastrointestinal, pediatric intensive care unit, 
neonatal intensive care unit, endoscopy ,neonatal, 
hematology, neurology, surgery, nephrology , 
respiratory, dialysis, emergency, laboratory, 
radiology and pediatric infectious research center 
)were studied.  
Two hundred (87.33%) were female and 29 
(12.66%) were male. No significant differences 
were observed in MRSA colonization between 
health care providers in various wards. 
Staphylococci were isolated in 27 cases (12%). 
MRSA were 21 cases (77.7%) and 6 cases (22.3%) 
were MSSA. No significant difference was 
between the age (p = 0.920), sex (p = 0.315) and 
different wards in of MRSA and MSSA carriers. 
Antibiotic resistant pattern in MRSA was more 
than MSSA but no significant difference was 
between them .MSSA was sensitive to most 
antibiotics. All strains in this study were sensitive 
to linezolid and vancomycin and the rate of 
penicillin resistance was high in both groups 
(Table1). 
 








    The worldwide emergence of MRSA is a 
remarkable challenge for public health [9-11]. 
Based on centers for disease control (CDC) 
reports, 1 % of all Staphylococcal infections and 
50 % of healthcare-associated Staphylococcal 
infections are caused by MRSA [3]. In 
examination of 229 samples, 21(12%) MRSA was 
detected. Similar with our study conducted in 
Germany 2007[12] and west of Iran 2013[13], the 
prevalence of MRSA isolates among health care 
carriers was reported 11.3% and 17.57%, 
respectively.  
Compared to Germany (6.5%), Dutch(1.4%), a 
study in Shiraz, Iran(5.3%), the other study in 
PIRC,Iran(3.2%),Switzerland(3.3%), the USA 
(3.4%), France (6.6%) and the UK(6.7%), the 
prevalence of MRSA was less than our study[14-
21]. Rezaei and, etal considered colonization with 
methicillin resistant and methicillin sensitive 
Staphylococcus aureus subtypes in patients with 
atopic dermatitis .They found a higher rate (33%) 
of MRSA colonization in the nasal cavity. 
Because, MRSA is one of the most organisms that 
find on their skin. The high percentage of MRSA 
in health care providers, especially who do not 
exhibit any symptoms or signs of severe disease is 
very dangerous. Because they can cause epidemic, 
raise the occurrence of severe diseases among 
patients, and enhance mortality rates by transfer the 
strains to patients [22]. Linezolid is one of the most 
effective oral medications used for outpatient 
treatment of MRSA infections that is resistant to 
other antibiotics. In this study, there was no 
resistance against linezolid in both groups [23]. 
MRSA nasal colonization isolates showed variable 
resistance to clindamycin, ceftriaxone, 
cefpodoxime, azithromycine, and erythromycin 
[23]. Resistant to penicillin and clindamycin [23, 
24] was similar with the other studies .Moderate 
resistance to other conventional antibiotics (such as 
azithromycin, erythromycin, clindamycin, 
cefpodoxim, ceftriaxon were detected in MRSA 
[22]. By definition, all MRSA isolates carry the 
mecA gene, which confers resistance to all beta-
lactam antibiotics, including cephalosporins and 
carbapenems .In our study and similar studies 
some MRSA are susceptible to some beta lactams 
such as cephalosporins[25].  
Some additional auxiliary factors, increase MRSA 
susceptibility to beta-lactams or other clinically 
used antibiotics. These auxiliary genes including 
femX (fmhB), murE, pbp2, SAV1220, SAV175 
and femD (glmM) were loyalty identified to give 
back beta-lactam susceptibility of MRSA strain 
context. [26] In every region, rating of resistance or 
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sensitivity of MRSA against conventionally 
antibiotics is different. When antimicrobials are 
considered for therapy, susceptibility testing for 
antibiotics for every isolate of MRSA should be 
done. This study showed that all MRSA isolates 
were significantly less sensitive to antibiotics 
compared with MSSA isolates [24]. A remarkable 
result in this study was high percentage of MRSA 
in health care providers. Unfortunately, it is 
thought that rate of MRSA in health care providers 
carriers are less than clinical samples. So, MRSA 
screening in these persons often don’t study or 
seldom examine in Iran. The best program for 
monitoring of MRSA spread and infection remains 
to debate formally. However, studies have 
consistently indicated that screening is 
advantageous in high-risk units to discover the 
reservoir and to begin contact cautions. 
Management programs may be useful in 
decreasing to occur the MRSA infection in health 
care providers’ carriers [27]. Current studies show 
highly change carrier rate ranging from 0% to 29% 
[23, 28-36]. 
Neerja Jindal and etal.  in 2013,studied the 
prevalence of inducible clindamycin resistance 
among clinical isolates of Mrsa in Malwa region of 
Punjab (north India). Of the total of 288 
Staphylococcal isolates studied, 116(40.27%) were 
found to be MRSA. 54 isolates were resistant to 
erythromycin but sensitive to clindamycin. D test 
showed that it was positive in 21(18.1%) indicating 
inducible clindamycin resistance. In MSSA, 
inducible clindamycin resistance was observed in 
10(5.81%).It was concluded that clindamycin 
could be used for the treatment of both MRSA and 
MSSA infections but after doing a simple, 
inexpensive D test ,and ruling out inducible 
resistance to clindamycin [6]. In study Deepa and 
et al. in 2013, among the 373 clinical isolates of 
Staphylococci which were studied, 134 isolates 
showed a discordant resistance pattern.  45 (33.6%) 
isolates were D-test positive, which had inducible 
clindamycin resistance and belonged to the 
inducible macrolide lincosamide streptogramin-B 
phenotype (MLSBi). 89 (66.4%) isolates were D-
test negative and they belonged to the macrolide 
streptogramin phenotype (MS). Among the MLSBi 
phenotypes, 6 (13.3%) isolates were methicillin-
resistant Staphylococcus aureus (MRSA). So, the  
 
D-test becomes an imperative part of the 
antimicrobial susceptibility tests for all the 
Staphylococcal isolates on a routine basis. Thus, 
clindamycin can be removed in patients with 
infections due to MLSBi phenotype, to avoid 
possible therapeutic failures. The increasing of the 
inducible resistance (MLSBi) compared with the  
 
constitutive (MLSBc) resistance among 
Staphylococci and the indiscriminate use of 
antimicrobials has deteriorated the sensitivity 
pattern [37,38]. Mahima Lall and etal. In 2014, 
16.6% of MRSA showed constitutive resistance 
and 37.5% inducible MLSBi resistance. 
Community associated MRSA (CA-MRSA) 
represented 10% of all isolates and had lower 
prevalence of MLSBi than hospital associated 
MRSA (HA-MRSA).They found a high prevalence 
of 20.3% of MLSBi amongst all staphylococcal 
isolates [39].  
 
Conventional methods for MRSA screening need 
to be reconsidered and only use of phenotypic 
approaches for detection should be abandoned. 
 
 Given the high rates of MRSA in health care 
providers in this study, detecting the carriers and 
decolonizing them to reduce transmission of S. 
aureus in the hospital is important. Annual 
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